GlassScriptPhysician profile
Adam Misasi
NPI 1063707438
$2,856.83
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $215 · 2021: $1,504 · 2022: $102 · 2023: $273 · 2024: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $744 · Travel and Lodging: $19.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.84 |
| Travel and Lodging | $19.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyocera Medical Technologies, INC. | $1,387.10 | 2021 | |
| Intuitive Surgical, INC. | $406.33 | 2019-2024 | |
| Enterra Medical, INC. | $364.73 | 2022-2024 | |
| Medtronic, INC. | $189.15 | 2022-2023 | Endoflip |
| Takeda Pharmaceuticals U.S.A., INC. | $118.06 | 2020-2021 | |
| Covidien LP | $100.67 | 2020 | |
| Shire North American Group INC | $52.59 | 2019 | |
| Ethicon US, LLC | $43.82 | 2019-2024 | Enseal, Surgicel Nu-Knit, Ethicon |
| Davol INC. | $43.67 | 2019 | |
| Stryker Corporation | $40.58 | 2020 | |
| Olympus America INC. | $27.13 | 2019 | |
| Glaxosmithkline, LLC. | $23.20 | 2022 | |
| Glaukos Corporation | $19.32 | 2021 | |
| Karl Storz Endoscopy-America | $14.98 | 2020 | |
| Smith+Nephew, INC. | $13.47 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Misasi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.